SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-1
Document Type: S-1
Date Filed: 2026-05-15
Accession Number: 0001213900-26-057939
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390026057939/ea0290954-s1_synergy.htm

Chunk 12 of 16
Word Count: 1318
Character Count: 8120

Document Content:

also may have the effect of reducing the likelihood of derivative litigation against officers and directors, even though such an action, if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions. We believe that these provisions and the indemnity agreements are necessary to attract and retain talented and experienced officers and directors. Listing Shares of our common stock are listed on the Nasdaq Capital Market under the symbol “SNYR”. Transfer Agent and Registrar The transfer agent and registrar for our common stock is VStock Transfer LLC, 18 Lafayette Place, Woodmere, New York 11598. LEGAL MATTERS The validity of the shares of common stock offered hereby will be passed upon for us by Nelson Mullins Riley & Scarborough LLP, Raleigh, North Carolina. EXPERTS

The consolidated financial
statements of Synergy CHC Corp. as of December 31, 2025 and 2024 and for the years then ended included in this prospectus have
been so included in reliance on the reports of RBSM LLP, an independent registered public accounting firm, which are included herein,
given on the authority of said firm as experts in auditing and accounting.

WHERE YOU CAN FIND MORE INFORMATION

This prospectus is part of
a registration statement that we filed with the SEC and does not contain all of the information set forth in the registration statement
and the exhibits to the registration statement. For further information with respect to us and the securities we are offering under this
prospectus, we refer you to the registration statement and the exhibits and schedules filed as a part of the registration statement. You
should rely only on the information contained in this prospectus. We have not authorized anyone else to provide you with different information.
We are not making an offer of these securities in any jurisdiction where the offer is not permitted. You should assume that the information
contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus
or any sale of our securities.

We file annual, quarterly and
current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public from commercial document
retrieval services and over the Internet at the SEC’s website at www.sec.gov.

We maintain a website at www.synergychc.com.
You may access our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports
filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act with the SEC free of charge at our website as soon as reasonably
practicable after such material is electronically filed with, or furnished to, the SEC. The information contained in, or that can be accessed
through, our website is not incorporated by reference into, and is not part of, this prospectus.

INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

The SEC’s rules allow
us to “incorporate by reference” information into this prospectus, which means that we can disclose important information
to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to
be part of this prospectus. Any statement contained in this prospectus or a previously filed document incorporated by reference will be
deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus modifies
or replaces that statement:

●	Annual Report on  Form 10-K  for the year ended
December 31, 2025 filed on April 1, 2026;

●	Those portions of our Definitive Proxy Statement on Schedule 14A
for our 2026 Annual Meeting of Stockholders filed with the SEC on April 30, 2026 that are incorporated by reference into our Annual
Report on Form 10-K for the year ended December 31, 2025;

●	Quarterly Report on  Form 10-Q  for the three months
ended March 31, 2026 filed on May 14, 2026;

●	Current Report on Form 8-K (excluding any reports
or portions thereof that are deemed to be furnished and not filed) filed on  March 3, 2026 , March 25, 2026 and May 11, 2026 ; and

●	Our registration statement on  Form 8-A  filed
on October 21, 2024.

We also incorporate by reference
any future filings made with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after (i) the date of
this registration statement and prior to effectiveness of this registration statement and (ii) the date of this prospectus and before
the termination of the offering of the securities included in this prospectus, however, we will not incorporate by reference any document
or portions thereof that are not deemed “filed” with the SEC, or any information furnished pursuant to Items 2.02 or 7.01
of Form 8-K or related exhibits furnished pursuant to Item 9.01 of Current Reports on Form 8-K.

We will provide, without charge,
to each person, including any beneficial owner, to whom a copy of this prospectus is delivered, upon such person’s written or oral
request, a copy of any and all of the information incorporated by reference in this prospectus. You may request a free copy of any of
the documents incorporated by reference in this prospectus by writing or telephoning us at the following address:

Synergy CHC Corp.

770 Roosevelt Trail STE 8 #1016

N. Windham, Maine 04062

Exhibits to the filings will
not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus.

101,710,000 Shares of Common Stock

Synergy CHC Corp.

PRELIMINARY PROSPECTUS

PART II — INFORMATION NOT REQUIRED
IN PROSPECTUS

Item 13.
Other Expenses of Issuance and Distribution.

The following table sets forth all costs and expenses, other than underwriting
discounts and commissions, paid or payable by us in connection with the sale of the common stock being registered. All amounts shown are
estimates except for the SEC registration fee.

Amount Paid or to be Paid

SEC registration fee $	4,214

Legal fees and expenses 100,000

Accounting fees and expenses 100,000

Total $	204,214

Item 14.
Indemnification of Directors and Officers.

Neither our articles of incorporation,
nor our amended and restated bylaws, prevent us from indemnifying our officers, directors and agents to the extent permitted under the
Nevada Revised Statutes (“NRS”). NRS Section 78.7502, provides that a corporation may indemnify any director, officer,
employee or agent of a corporation against expenses, including attorneys’ fees, actually and reasonably incurred by him in connection
with any defense to the extent that a director, officer, employee or agent of a corporation has been successful on the merits or otherwise
in defense of any action, suit or proceeding referred to Section 78.7502(1) or 78.7502(2), or in defense of any claim, issue
or matter therein.

NRS 78.7502(1) provides
that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed
action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the corporation,
by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request
of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise,
against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by
him in connection with the action, suit or proceeding if he: (a) is not liable pursuant to NRS 78.138; or (b) acted in good
faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect
to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful.